G352
Pill imprint G352 has been identified as Fenofibrate 160 mg.
Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type v, elevated chylomicrons vldl; hyperlipoproteinemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy.
Fenofibrate 160 mg is not subject to the Controlled Substances Act.
See also related documents.
Fenofibrate Images
- Imprint:
-
G352
- Strength:
- 160 mg
- Color:
- White
- Size:
- 15.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- croscarmellose sodium
hypromellose
magnesium stearate
microcrystalline cellulose
hypromellose 2910 (3 mPa.s)
hypromellose 2910 (6 mPa.s)
hypromellose 2910 (50 mPa.s)
polyethylene glycol
polydextrose
titanium dioxide
triacetin
- Drug Class:
- Fibric acid derivatives
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Global Pharmaceuticals
- National Drug Code (NDC):
- 00115-5522
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68084-0328 | Amerisource Health Services |
Note: Inactive ingredients may vary.
Advertisement
More Fenofibrate resources
- Fenofibrate
- CIP - Fenofibrate (Wolters Kluwer)
- Fenofibrate (Wolters Kluwer)
- fenofibrate (Cerner Multum)
- fenofibrate (Micromedex) - Includes Dosage Information
- Fenofibrate (AHFS DI)
- Fenofibrate (FDA)
- Lofibra Capsules (FDA)
- Fenofibrate (Wolters Kluwer)
Search Again
